Testicular germ cell tumors are important neoplasms and seminoma accounts for 40 to 50% of these tumors. Little is known concerning the molecular events underlying the development of these malignancies. In the present study we used a modified differential display approach to compare gene expression between seminoma and normal testicular parenchyma, both of which are mixed tissues. We first analyzed mRNA (cDNA) expression by differential display and then directly used differentially expressed cDNAs for the synthesis of radiolabeled riboprobes to attribute differential expression to specific cell types in tissue sections by in situ hybridization. Testicular germ cell tumors are common malignancies between the age of 15 and 35 years. They arise by transformation of early germ cell precursors and can differentiate into either embryonal or extra-embryonal directions. Seminoma is considered the most undifferentiated and is the most frequent of these tumors accounting for 40 to 50% of testicular germ cell tumors. Little is known about the molecular events underlying the development of these important neoplasms. In seminomas it is the KIT oncogene that is overexpressed and in nonseminomas it is the mast cell growth factor (MGF). Tumor suppressor genes supposed to be involved in testicular germ cell tumor development include DCC (deleted in colon cancer), RB1 (retinoblastoma), as well as NME1 and 2 (nucleoside diphosphate kinase).
Testicular germ cell tumors are common malignancies between the age of 15 and 35 years. They arise by transformation of early germ cell precursors and can differentiate into either embryonal or extra-embryonal directions. Seminoma is considered the most undifferentiated and is the most frequent of these tumors accounting for 40 to 50% of testicular germ cell tumors. Little is known about the molecular events underlying the development of these important neoplasms. In seminomas it is the KIT oncogene that is overexpressed and in nonseminomas it is the mast cell growth factor (MGF). Tumor suppressor genes supposed to be involved in testicular germ cell tumor development include DCC (deleted in colon cancer), RB1 (retinoblastoma), as well as NME1 and 2 (nucleoside diphosphate kinase). 1, 2 Differential display is one of several methods, which allows the identification of new cancer genes by comparing gene expression of normal and neoplastic cells. 3, 4 Application of this method to most human tumors is nevertheless hampered by the fact that tumor tissue not only contains neoplastic but also stromal cells (such as fibroblasts, endothelial, or inflammatory cells), which can mask differences in gene expression between neoplastic cells and their normal counterparts. Seminoma, in particular, contains a great number of inflammatory cells (mainly lymphocytes and macrophages) in the stroma. Moreover normal testicular parenchyma is also a mixture of germinal and other cell types such as Sertoli and Leydig cells. Comparison of mRNA expression between seminoma and normal testicular tissue by differential display and Northern blotting alone would therefore not be sufficient to attribute expression differences to specific cell types. In the present investigation we solved this problem by first comparing mRNA expression of normal testicular parenchyma and seminomas by conventional differential display and then localizing differentially expressed transcripts to specific cell types by in situ hybridization with riboprobes, which we synthesized directly from the differentially expressed cDNAs. In addition we verified differential expression by real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), with which we could demonstrate a significant overexpression of eukaryotic initiation factor 3 (elF3-p110) mRNA in seminoma cells compared to that of normal germ cell precursors in testicular tubules. Overexpression of this elF3 subunit may promote seminoma development by generally increasing translation leading to enhanced cellular growth and division rates.
Materials and Methods

Tissue Samples
We examined 25 human testicular seminomas and compared them with seven normal testicular biopsies taken during infertility diagnosis for other than testicular reasons. Patients were 19 to 49 years old. We immediately froze parts of each sample in Ϫ150°C isopentane (precooled in liquid nitrogen) for RNA extraction, to preserve histomorphology. In parallel, we fixed parts of the biopsies in 4% paraformaldehyde (for 24 hours at 4°C) for in Supported by the BONFOR program (199 A/01) of the Faculty of Medicine, University of Bonn, Germany.
Accepted for publication July 20, 2000. situ hybridization and routinely embedded these samples into paraffin. Histological evaluation was done on frozen or paraffin sections stained with hematoxylin and eosin (H&E). In all cases biopsies were evaluated as normal and free of preneoplastic germ cell alterations.
Cryo-Microdissection and RNA Extraction
We microscopically selected areas from normal testicular parenchyma or seminomas on frozen sections and trimmed the tissue blocks to the size of these areas at Ϫ20°C using a sterile scalpel. We then cut 30 20-mthick sections from these blocks using a cryostat and immediately placed them into liquid nitrogen. Histology was again verified during this process at regular intervals on H&E-stained sections.
We isolated total cellular RNA from microdissected tissues with Trizol (Gibco-BRL, Karlsruhe, Germany) after evaporation of the liquid nitrogen using 750 l of Trizol for 30 slides. We performed extraction according to the manufacturer's instructions. We then treated RNA with DNase I (Roche, Mannheim, Germany) to remove genomic DNA. We quantified RNA by spectrophotometry and verified RNA integrity by electrophoresis of 4 g of total RNA in a 2% agarose gel that had been stained with ethidium bromide.
Differential Display
We used six base-anchored oligonucleotide primers (5Ј-T 11 CA-3Ј, 5Ј-T 11 CG-3Ј, 5Ј-T 11 AC-3Ј, 5Ј-T 11 GC-3Ј, 5Ј-T 11 CC-3Ј, and 5Ј-T 11 GG-3Ј) to reverse-transcribe 4 g of total cellular RNA into first strand cDNA. We subsequently amplified the cDNA using the same primers together with 10 arbitrary primers (5Ј-TACAACGAGG-3Ј, 5Ј-TGGATTGGTC-3Ј, 5Ј-CT-TTCTACCC-3Ј, 5Ј-TTTTGGCTCC-3Ј, 5Ј-GGAACCAATC-3Ј, AAACTCCGTC-3Ј, 5Ј-GATCTGACTG-3Ј, 5Ј-GATCATGGTC-3Ј, 5Ј-GATCATAGCG-3Ј, and 5Ј-GATCTAAGGC-3Ј). PCR conditions are as described by Liang. 5 We analyzed PCR products on 8% DNA sequencing gels after silver-staining. 6 We excised bands from the cDNA ladders, which exhibited differences of intensities between normal and tumor tissue DNA and extracted them by 15 minutes cooking. This was followed by precipitation with sodium acetate (0.25 mol/L final concentration, pH 4.6) and reamplification with the same primers under the same PCR conditions described above. We electrophoresed reamplified cDNAs in a 2% agarose gel, cut them out, and extracted them with the QIAEX DNA extraction kit (Qiagen, Hilden, Germany) for further cloning.
Cloning and Sequencing
We ligated reamplified cDNA fragments into the pCRII vector using the TA Cloning kit (Invitrogen, Groningen, The Netherlands). We then transformed competent cells (Escherichia coli TOP10FЈ) with the plasmids by heat shock. Transformed cells were plated on ␤-X-Gal LBagar and incubated for 18 hours at 37°C. We picked white colonies containing plasmids with inserts, transferred them into 3 ml of Luria-Bertani medium (supplemented with 70 g/ml ampicillin), and incubated them for 12 hours at 37°C.
We then prepared plasmids by using the Qiagen Plasmid Purification Kit. We amplified individual plasmids for cycle sequencing with the M13-forward and the M-13 reverse sequencing primer using the ABI prism Terminator Cycle Sequencing Ready Reaction Kit (PE Biosystems, Weiterstadt, Germany). We sequenced at least 20 clones of one transformation using an ABI Prism 310 sequencer (PE Biosystems). Sequences were aligned to the human genome database with the BLAST program. 7 
In Situ Hybridization
We cut out the elF3-p110 insert from pCRII and subcloned it in pBluescript to synthesize radiolabeled riboprobes by in vitro transcription, 8 -10 Riboprobes were labeled with 35 S-CTP (70 Ci/l; Du Pont-New England Nuclear Research Products, Boston, MA) using an in vitro transcription kit (Promega, Mannheim, Germany). For in vitro transcription we linearized 10 g of the recombinant plasmid containing the 200-bp elF-3 insert with either EcoRV or BamHI to generate sense or antisense riboprobes. Probes were synthesized for 2 hours (at 37°C in 1ϫ transcription buffer) using SP6 or T7 RNA polymerase. We measured probe activity in a scintillation counter (Canberra-Packard, Zürich, Switzerland).
For in situ hybridization we routinely embedded the fresh tissue samples, which had been immediately fixed in 4% paraformaldehyde (for 24 hours at 4°C) into paraffin. We transferred 5-m-thick paraffin sections on silanized slides (Superfrost; Menzel, Heidelberg, Germany) and dried them overnight at 42°C. After deparaffinization and rehydration, we incubated slides in 0.1 mol/L glycine and 0.2 mol/L Tris-HCl (pH 7.4) for 10 minutes at room temperature, treated them with proteinase K (1 g/ml, 15 minutes at 37°C; Gibco-BRL) and refixed them for 15 minutes in 4% paraformaldehyde in phosphate-buffered saline (PBS). Slides were then washed in PBS, acetylated, and dehydrated. 11 We denaturated probes immediately before hybridization at 80°C for 2 minutes and diluted them in hybridization buffer 11 (riboprobe activity: 20 ϫ 10 3 cpm/l). Hybridization was performed for 16 hours at 60°C in sealed boxes. We then washed slides in 4ϫ standard saline citrate (SSC) at room temperature and treated them with RNase A (10 g/ml, 30 minutes at 37°C; Roche). We performed stringent washes in 2ϫ SSC and 0.1ϫ SSC at 60°C for 10 minutes each. We finally dehydrated slides, dipped them in nuclear track emulsion (NTB2; Kodak, Rochester, NY), and exposed them at 4°C for 10 to 15 days for autoradiography. After development we counterstained nuclei with bisbenzimidine (Hoechst 33258) 12 and evaluated results in fluorescent light under dark-field illumination (with Axioscop 50, Zeiss, Gö ttingen, Germany) to visualize silver grains.
Real-Time Quantitative RT-PCR of EIF3S8 mRNA and the Housekeeping Gene TATABinding Protein (TBP)
To quantify EIF3S8 mRNA expression in addition to in situ hybridization we needed to establish a real-time quantitative RT-PCR approach for both the EIF3S8 gene and for the housekeeping gene TBP (TATA binding protein), because the precise amount of total RNA added to each reaction and its quality are difficult to estimate. No retropseudogenes are known for TBP and the expression level is in the range of the EIF3S8 target gene. 13 The amount of targets and endogenous reference was determined from standard curves for each experimental sample. To obtain a normalized target value the target amount was divided by the endogenous reference amount (EIF3S8/TBP). During real-time quantitative RT-PCR analysis of EIF3S8 expression, we compared seminoma samples with tumor-free testicular parenchyma from the same patients (n ϭ 7).
Construction of cRNA Standards for EIF3S8 and TBP
After reverse transcription of 4 g of total cellular RNA from each of the seminoma and or normal testicular parenchyma tissue into first strand cDNA we performed specific PCR-amplification with the designed primers shown in Table 1 . We then constructed oligonucleotides as described in Totzke et al 14 with a T7 promotor at the 5Ј PCR primers and an oligo-dT at the 3Ј primers to perform in vitro transcription of EIF3S8 and TBP cDNAs. We reamplified EIF3S8 and TBP cDNA with these primers and visualized fragments on a 1.5% agarose gel. We then used 1 g of cDNA from each PCR reaction for in vitro transcription (MEGAscript T7 kit; Ambion, Austin, TX), after which we removed cDNA by digestion with RNasefree DNase I (for 15 minutes at 37°C). We stopped reactions and precipitated cRNAs by adding RNase-free dH 2 O and lithium chloride (incubation for at least 30 minutes at Ϫ20°C). We finally quantified cRNAs (based on absorbance) and made a dilution series from 10 11 to 10 5 transcripts l Ϫ1 in 20-l tRNA samples (1:100 dilution of brewer's yeast tRNA in diethyl pyrocarbonate-dH 2 O; Roche).
Real-Time PCR Quantification
We first reverse-transcribed 4 g of total RNA from seminoma and normal testicular tissues and decreasing amounts of EIF3S8 and TBP cRNA in the range from 10 We next performed PCR on a Light-Cycler (Roche) additionally using hybridization probes in combination with the Light-Cycler DNA Master Hybridization Probes Kit (Roche). Primers used for amplification and hybridization (TIB Molbiol, Berlin, Germany) of EIF3S8 and TBP cDNAs are given in Table 1 . In principle, hybridization is performed in addition to primer annealing during LightCycler PCR with two different short oligonucleotides that hybridize to two adjacent internal sequences of the PCR fragment during the annealing phases. One probe is 5Ј-labeled with Light-Cycler-Red fluorophore and the other with fluorescein. Probes come into close proximity after specific hybridization resulting in fluorescence resonance energy transfer between the two fluorophores when the donor fluorophore, fluorescein, is stimulated by the light source of the cycler. Parts of the absorbed energy are transferred to the acceptor fluorophore, LightCycler-Red, the emitted fluorescence of which is finally measured. The PCR reaction mixture contained 2 mmol/L MgCl 2 , 20 pmol of both PCR primers, 1 pmol of each hybridization probe, 2 l of Light-Cycler DNA Master Hybridization Mix (Roche), and 2 l of reverse-transcribed samples in a final volume of 20 l. After 3 minutes of denaturation (at 94°C) we performed 45 PCR cycles with 3 seconds of denaturation at 94°C, 20 seconds for EIF358 and 15 seconds for TBP (EIF3S8/TBP) of annealing at 63/60°C (EIF3S8/TBP), and 20 seconds of extension at 72°C. The larger the starting quantity of the target molecule, the earlier a significant increase in fluorescence caused by fluorescence resonance energy transfer is detected during on-line monitoring of PCR by the Light-Cycler. This point of first detection is the main pa- 
Northern Hybridization
We separated total cellular RNAs of normal or seminoma tissue on denaturating 1.3% agarose gels (1.5% formaldehyde, v/v) and transferred them to nylon membranes (Hybond N; Amersham, Braunschweig, Germany). To obtain a probe for hybridization we cut out the EIF3S8 insert by EcoRI digestion and labeled it with 32 P-dCTP using the Rediprime II DNA labeling kit (Amersham). We hybridized membranes with the probe overnight at 42°C. 28S and 18S bands in the gel before blotting were used as a control for equal loading. We performed washes in 2ϫ SSC, 0.1% sodium dodecyl sulfate, and in 1ϫ SSC, 0.1% sodium dodecyl sulfate at 60°C (15 minutes each), and exposed membranes during autoradiography for 1 to 7 days at Ϫ70°C.
Results
Overexpression of elF3-p110 mRNA (EIF3S8) in Seminomas Found by Differential Display
We first performed differential display RT-PCR to detect differences in gene expression between normal testicular parenchyma and seminomas. Using the 60 primer pairs we found a total of 78 bands which showed slight to strong differences of intensity between seminoma and normal testicular tissues. Using the primer pair 5Ј-T 11 CG-3Ј and 5Ј-TACAACGAGG-3Ј we detected large amounts of a cDNA fragment (of ϳ200 bp), in all seminoma samples, whereas only weak or no signals were seen in normal testicular parenchyma (Figure 1 ). Because this fragment showed the greatest difference between seminoma and normal testicular tissue, we subcloned and sequenced it and aligned the sequence to the human genome database using the BLAST program. 7 The sequence was 100% homologous (133 of 133 bases) to the mRNA of the p110 subunit of the eukaryotic initiation factor 3 (EIF3S8) (accession number: U46025).
Cellular Localization of elF3-p110 mRNA and Confirmation of Differential Expression Using in Situ Hybridization
We next wanted to identify the cell types that express elF3-p110 mRNA in normal testis and in seminomas and to confirm differential expression. We therefore synthesized 35 S-CTP-labeled riboprobes by in vitro transcription using the sequenced elF3-p110 (EIF3S8) cDNA subclone as a template. We analyzed 10 seminomas and compared them to seven normal testicular biopsies. In situ hybridization revealed that elF3-p110 transcripts are expressed by the normal germinal epithelium of the testicular tubules and by the tumor cells of seminomas. On the other hand the interstitial testicular tissue as well as the seminoma stroma exhibited only weak signals or none at all (Figure 2 ). In six of the 10 seminomas the intensity of signals turned out to be clearly stronger in seminoma cells than in normal germ cells (Figure 2) .
Verification of elF3-p110 (EIF3S8) mRNA Overexpression in Seminomas by Quantitative Real-Time RT-PCR
For real-time RT-PCR analysis of EIF3S8 expression we established standard curves for EIF3S8 and TBP using the serially diluted cRNA (10 5 to 10 11 transcripts) obtained by in vitro transcription. Figure 3A shows the standard curves for the EIF3S8-gene. The dynamic range was wide (at least five orders of magnitude). A strong linear relationship between the fractional cycle number and the log of the starting copy number was demonstrated (Figure 3B) . For determination of the total amount of EIF3S8 transcripts in 2 g of total tissue RNA, we reverse-transcribed and amplified tissue samples during real-time RT-PCR together with the standard samples ( Figure 3A) . We applied the same approach for the analysis of TBP housekeeping gene expression and determined the amounts of both EIF3S8 and TBP mRNAs in the samples from the standard curves. To obtain a normalized value Figure 1 . Comparison of mRNA (cDNA) expression between seminomas (n ϭ 9) and normal testicular parenchyma (n ϭ 6) by differential display. Differential display was performed after retrotranscription of total cellular mRNA into cDNA and PCR using a 5Ј arbritary primer (5Ј-TACAACGAGG-3Ј) and a 3Ј anchored primer (5Ј-TTTTTTTTTTTCG-3Ј). PCR conditions were as described in Liang. 5 Amplified cDNA fragments were separated in an 8% acrylamide gel. A fragment of ϳ200 bp (arrow) is strongly displayed in all seminoma samples (T) but only weakly discernible in normal testicular parenchyma (N). Subcloning and sequencing of this fragment revealed a 100% homology (133 of 133 bases) to the mRNA of the elF3-p110 subunit.
for EIF3S8 mRNA for each tissue sample we divided EIF3S8 amounts by TBP amounts.
We found a mean relative amount for EIF3S8 transcripts of 6.225 Ϯ 1.075 (EIF3S8/TBP, SDϮSEM) in seven seminoma samples, compared to 3.161 Ϯ 0.513 in seven normal testicular tissues. Results are given in Table 2 . The difference between the values for seminoma and normal samples was significant with a z-value of Ϫ2.364 (P Ͻ 0.05). 15 
Verification of elF3-p110 (EIF3S8) Overexpression in Seminomas by Northern Blotting
In four cases of seminoma and normal testicular biopsies sufficient amounts of mRNA were left after quantitative RT-PCR for Northern blot analyses. Using radiolabeled elF3-p110 probes, which had been synthesized by ran- . Differential display of seminoma and testicular cDNA followed by Northern blotting can, therefore, yield no information about the cell types which are responsible for expression differences. We solved this problem by first comparing cDNA expression of normal and seminoma tissues and then directly synthesizing RNA probes from differentially expressed cDNAs for in situ hybridization. Using this strategy we could attribute The EIF3S8 mRNA copy number was divided by the TBP mRNA copy number for each sample in order to obtain a normalized EIF3S8/TBP value. *S, seminoma; N, normal. expression of elF3 (p110) mRNA (EIF3S8) to normal testicular germ cells and to the tumor cells of seminomas. At the same time we could confirm elF3-p110 mRNA overexpression in six of 10 tumors investigated. We additionally verified EIF3S8 overexpression in seminomas by quantitative real-time RT-PCR and Northern blot analyses.
Eukaryotic initiation factors (elFs) are a complex system of many cellular proteins, which are necessary for the first steps of translation. The elF3 complex (650 kd), in particular, is composed of 10 subunits, one of the largest of which is p110 (913 amino acids). 16, 17 The whole elF3 complex recognizes the first AUG initiation codon closest to the 5Ј end of the mRNA. 18 ElF2 carries the Met-tRNA to the 40S subunit of the ribosome. The elF4 complex consisting of four subunits, stabilizes the mRNA by binding to the cap (7-methyl guanosine, m 7 GpppN). 18, 19 Its elF4G subunit is thought to establish a bridge between elF3 and elF4E. 20, 21 Several lines of evidence suggest a role of eukaryotic initiation factors in tumor development. 22 NIH3T3 cells transfected with elF4E expression vectors undergo malignant phenotypic changes. 23 Moreover elF2␣, elF4E, or elF4␥ have been found to be overexpressed in transformed cell lines and in human tumors such as breast, lung, head, and neck cancers. 19,24 -27 A different elF3 subunit (elF3-p40), from the one investigated in this study (EIF3S8), has recently been reported to be overexpressed in human breast and prostate cancer, underlining the concept that overexpression of eukaryotic initiation factors may be a common feature of different tumors. 28 A general increase in translation by overexpressed eukaryotic initiation factors is thought to accelerate cell growth leading to an early entrance of the cell into the cell cycle and consequently to an increased cell division rate. 22, 29 We suggest that an augmented translation of oncogenic proteins may be another mechanism by which eukaryotic initiation factors promote tumor growth including that of seminomas. Functional studies are required to prove such a role or other functions for tumor development and progression.
EIF3S8 is located at 16p11.2. The possible causes of EIF3S8 overexpression in seminomas include gene amplification, translocation, or differential transcriptional regulation (for example by alterations of methylation). Instead of gains or amplifications losses of chromosomal material were found at 16p in seminomas in several comparative genomic hybridization and loss of heterozygosity studies. 30 -32 Nothing is presently known concerning other possible mechanisms of EIF3S8 overexpression in seminomas. They will likewise have to be addressed in further studies.
